| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMSI | Common Stock, No Par Value | Sale | -$1.18M | -11.3K | -1.01% | $104.05 | 1.11M | 05 Mar 2025 | Direct | F3 |
| transaction | MMSI | Common Stock, No Par Value | Sale | -$2.08M | -20K | -1.81% | $103.75 | 1.09M | 05 Mar 2025 | Direct | F4 |
| transaction | MMSI | Common Stock, No Par Value | Sale | -$42.5K | -410 | -3.82% | $103.75 | 10.3K | 05 Mar 2025 | By spouse | F2 |
| transaction | MMSI | Common Stock, No Par Value | Sale | -$269K | -2.59K | -25.09% | $103.75 | 7.73K | 05 Mar 2025 | By spouse | F2 |
| holding | MMSI | Common Stock, No Par Value | 97.8K | 05 Mar 2025 | By 401(k) Plan | F1 | |||||
| holding | MMSI | Common Stock, No Par Value | 90 | 05 Mar 2025 | By spouse as custodian for child | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | MMSI | Non-qualified stock options (right to buy) | 159K | 05 Mar 2025 | Common Stock | 159K | $55.73 | Direct | F5 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 2K | 05 Mar 2025 | Common Stock | 2K | $55.73 | By spouse | F2, F6 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 100K | 05 Mar 2025 | Common Stock | 100K | $37.71 | Direct | F7 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 58.1K | 05 Mar 2025 | Common Stock | 58.1K | $56.25 | Direct | F8 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 54.3K | 05 Mar 2025 | Common Stock | 54.3K | $70.58 | Direct | F9 |
| Id | Content |
|---|---|
| F1 | Represents plan holdings as of 02/28/2025. |
| F2 | Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse. |
| F3 | The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.00 to $104.22, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F4 | The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.75 to $103.765, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F5 | Becomes exercisable in equal annual installments of 20% commencing 3/1/2020. |
| F6 | Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited. |
| F7 | Becomes exercisable in equal annual installments of 25% commencing 2/26/2021. |
| F8 | Becomes exercisable in equal annual installments of 25% commencing 03/19/2022. |
| F9 | Becomes exercisable in equal annual installments of 25% commencing 2/28/2024. |